🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rohinton S. Tarapore

Jazz Pharmaceuticals (United States)

ORCID: 0000-0002-8070-5646

Also affiliated with Chimerix (United States), Cancer Research Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma”.

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Neuro-Oncology(2022)10.1093/neuonc/noac030

N/A

3.4DataRank · unranked

122 citations

Kyle Wierzbicki, Rohinton S. Tarapore, Karthik Ravi, Chase Thomas, Rodrigo T. Cartaxo +27 more

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3615

N/A

0DataRank · unranked

2 citations

Sylvia C. Kurz, Rohinton S. Tarapore, Ashley Sumrall, Nicholas Butowski, Rebecca A. Harrison +15 more

ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3619

N/A

0DataRank · unranked

0 citations

Carl J. Koschmann, Rohinton S. Tarapore, Jeffrey C. Allen, Wafik Zaky, Yazmín Odia +14 more

ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0386

N/A

0DataRank · unranked

19 citations

Ramona Dadu, Lei Ye, Yaashmin Shiny Jebaraj, Jade A. Martinez, Junsheng Ma +6 more

Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436

Cancers(2021)10.3390/cancers13040623

N/A

0DataRank · unranked

1 citations

Li Zhang, Sammy Ferri‐Borgogno, Suet‐Ying Kwan, Kelsey Lewis, Han Cun +9 more

Window-of-opportunity study of ONC201 in pediatric patients with diffuse intrinsic pontine glioma (DIPG) and thalamic glioma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps2082

N/A

0DataRank · unranked

3 citations

Carl J. Koschmann, Rohinton S. Tarapore, Jeffrey C. Allen, Wafik Zaky, Matthew D. Hall +12 more

Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype

Cancers(2020)10.3390/cancers12092436

N/A

0DataRank · unranked

11 citations

Li Zhang, Sammy Ferri‐Borgogno, Suet‐Ying Kwan, Kelsey Lewis, Han Cun +9 more

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0131

N/A

0DataRank · unranked

154 citations

Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota +79 more